And It's Back to the Drawing Board for PDE9 Inhibition in Heart Failure

(MedPage Today) -- PHOENIX -- The development of a PDE9 inhibitor for heart failure hit a major roadblock, as two phase II placebo-controlled trials were suspected of having tested the wrong dose. In both heart failure with reduced ejection...

Read it at MedPage Today ↗

← Front page